Serious Bacterial Infections: Successful Outpatient Management by Infectious Disease Physicians in Office Infusion Centers

John S. Adams – Knoxville Infectious Disease Consultants, Knoxville, TN
Brian S. Metzger – Austin Infectious Disease Consultants, Austin, TX
Richard M. Mandel – Southern Arizona Infectious Disease Specialists, Tucson, AZ
Thomas K. Sleweon – Infectious Disease Doctors Medical Group, Walnut Creek, CA
Robin H. Dretler – Infectious Disease Specialists of Atlanta, Decatur, GA
Barry Statner – Mazur, Statner, Dutta, Nathan, PC, Thousand Oaks, CA
Jorge R. Bernett – Infectious Disease Specialists of Indiana, Highland, IN
Claudia P. Schroeder – Healix Infusion Therapy, Sugar Land, TX
Thomas C. Hardin – Healix Infusion Therapy, Sugar Land, TX
Lucinda J. Van Anglen – Healix Infusion Therapy, Sugar Land, TX

View Poster

View All

Phase II and Phase III Studies

Healix regularly and actively supports Phase II and Phase III clinical trials in each of our specialty areas, including active studies in therapies for COVID-19, Multiple Sclerosis and Intestinal Bowel Disease.

For information on partnering with Healix on a study, please contact us.